The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...

GAITHERSBURG, Md. - GeneDx (NASDAQ:WGS), a genomic insights company with a market capitalization of $1.95 billion, announced the introduction of its ultraRapid Whole Genome Sequencing service, which ...

Biomedical engineers at Duke University have demonstrated a promising new approach that could be used to treat a rare and ...

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Originally found mostly in wild birds and poultry, H5N1 clade 2.3.4.4b, genotype D1.1, was discovered in dairy cattle last ...

Researchers at Washington University School of Medicine in St. Louis have conducted a longitudinal study on an individual ...

A groundbreaking study reveals how a rare combination of genetics, proteomics, and environmental factors may hold the key to ...

A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and ...

Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...

BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

Tick-borne encephalitis virus (TBEV) has now been confirmed in locally acquired human cases in the U.K., with evidence of ...